Panacea Biotec posts Q1 FY24 consolidated PAT at Rs. 10.98 Cr
Panacea Biotec has reported total income of Rs. 135.27 crores during the period ended June 30, 2023
Panacea Biotec has reported total income of Rs. 135.27 crores during the period ended June 30, 2023
IPCA Laboratories has reported total income of Rs. 1632.43 crores during the period ended June 30, 2023
The company has reported total income of Rs. 75.26 crores during the period ended June 30, 2023
Hester Biosciences has reported total income of Rs. 88.99 crores during the period ended June 30, 2023
Suven Life Sciences has reported total income of Rs. 9.43 crores during the period ended June 30, 2023
Natural Capsules Ltd. has reported total income of Rs. 37.87 crores during the period ended June 30, 2023
IOL Chemicals and Pharmaceuticals has reported total income of Rs. 570.24 crores during the period ended June 30, 2023
Dishman Carbogen Amcis has reported total income of Rs. 729.91 crores during the period ended June 30, 2023
US FDA approval is in line with de-risking strategy for additional API site to service our global customer base
KIMS has reported total income of Rs. 609.14 crores during the period ended June 30, 2023
Subscribe To Our Newsletter & Stay Updated